354 related articles for article (PubMed ID: 28199666)
1. The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.
Wang Y; Yin F; Guo H; Zhang J; Yan P; Lai J
Int J Neuropsychopharmacol; 2017 Jul; 20(7):562-574. PubMed ID: 28199666
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 and D3 Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice.
Zhu Y; Wang Y; Lai J; Wei S; Zhang H; Yan P; Li Y; Qiao X; Yin F
Int J Neuropsychopharmacol; 2017 Mar; 20(3):257-268. PubMed ID: 27815417
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 receptor-regulated NR2B subunits of N-methyl-d-aspartate receptors in the nucleus accumbens involves in morphine-induced locomotor activity.
Liu XS; Hou Y; Yan TL; Guo YY; Han W; Guan FL; Chen T; Li T
CNS Neurosci Ther; 2014 Sep; 20(9):823-9. PubMed ID: 24797707
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
[TBL] [Abstract][Full Text] [Related]
5. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
6. Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation.
Karasinska JM; George SR; Cheng R; O'Dowd BF
Eur J Neurosci; 2005 Oct; 22(7):1741-50. PubMed ID: 16197514
[TBL] [Abstract][Full Text] [Related]
7. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
Haberny SL; Carr KD
Neuroscience; 2005; 132(4):1035-43. PubMed ID: 15857708
[TBL] [Abstract][Full Text] [Related]
8. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
9. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.
Daigle TL; Wetsel WC; Caron MG
Eur J Neurosci; 2011 Nov; 34(9):1378-89. PubMed ID: 22034973
[TBL] [Abstract][Full Text] [Related]
10. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
Wlaź P
Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 but not D3 receptor is critical for spatial learning and related signaling in the hippocampus.
Xing B; Kong H; Meng X; Wei SG; Xu M; Li SB
Neuroscience; 2010 Sep; 169(4):1511-9. PubMed ID: 20600656
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
13. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal.
Anderson EM; Reeves T; Kapernaros K; Neubert JK; Caudle RM
J Pharmacol Exp Ther; 2015 Dec; 355(3):496-505. PubMed ID: 26377910
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses.
Wang YP; Wei SG; Zhu YS; Zhao B; Xun X; Lai JH
Genet Mol Res; 2015 Jan; 14(1):180-9. PubMed ID: 25729949
[TBL] [Abstract][Full Text] [Related]
16. Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.
Dykstra LA; Fischer BD; Balter RE; Henry FE; Schmidt KT; Miller LL
Behav Pharmacol; 2011 Sep; 22(5-6):540-7. PubMed ID: 21712708
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
[TBL] [Abstract][Full Text] [Related]
18. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
19. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D
Rodgers HM; Lim SA; Yow J; Dinkins ML; Patton R; Clemens S; Brewer KL
Pharmacol Biochem Behav; 2020 Jul; 194():172935. PubMed ID: 32335101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
